A

Alkahest, Inc.

75 employees

Alkahest develops therapies derived from blood to treat neurological diseases, with an emphasis on age-related cognitive decline.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Health Care
Medical

Date founded

2014

Funding rounds raised

Total raised

$38M

from 1 investors over 1 rounds

A

Alkahest, Inc. raised $38M on March 4, 2015

Investors: Grifols

FAQ